| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K27986637 | CTRPv2 | pan-cancer | AAC | -0.0042 | 1 |
| mRNA | etoposide | GDSC1000 | pan-cancer | AAC | 0.0021 | 1 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | -0.0027 | 1 |
| mRNA | tacrolimus | CTRPv2 | pan-cancer | AAC | 0.0019 | 1 |
| mRNA | S-Trityl-L-cysteine | GDSC1000 | pan-cancer | AAC | 0.0026 | 1 |
| mRNA | AZD7762 | GDSC1000 | pan-cancer | AAC | 0.0015 | 1 |
| mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | 0.0016 | 1 |
| mRNA | HG-5-113-01 | GDSC1000 | pan-cancer | AAC | -0.0021 | 1 |
| mRNA | BRD-K45681478 | CTRPv2 | pan-cancer | AAC | -0.0016 | 1 |
| mRNA | pifithrin-alpha | CTRPv2 | pan-cancer | AAC | 0.0016 | 1 |